316 related articles for article (PubMed ID: 34181884)
1. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
2. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
[TBL] [Abstract][Full Text] [Related]
3. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
[TBL] [Abstract][Full Text] [Related]
4. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
Braga A; Campos V; Filho JR; Lin LH; Sun SY; de Souza CB; da Silva RCAF; Leal EAS; Silveira E; Maestá I; Madi JM; Uberti EH; Viggiano M; Elias KM; Horowitz N; Berkowitz RS
Gynecol Oncol; 2018 Feb; 148(2):239-246. PubMed ID: 29248195
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis.
Weng Y; Liu Y; Benjoed C; Wu X; Tang S; Li X; Xie X; Lu W
J Zhejiang Univ Sci B; 2022 Mar; 23(3):218-229. PubMed ID: 35261217
[TBL] [Abstract][Full Text] [Related]
6. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
7. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
8. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
Chapman-Davis E; Hoekstra AV; Rademaker AW; Schink JC; Lurain JR
Gynecol Oncol; 2012 Jun; 125(3):572-5. PubMed ID: 22449733
[TBL] [Abstract][Full Text] [Related]
9. Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Cioffi R; Bergamini A; Gadducci A; Cormio G; Giorgione V; Petrone M; Rabaiotti E; Pella F; Candiani M; Mangili G
Int J Gynecol Cancer; 2018 Feb; 28(2):332-337. PubMed ID: 29324534
[TBL] [Abstract][Full Text] [Related]
10. Treatment of low-risk gestational trophoblastic neoplasia.
Winter MC
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():67-80. PubMed ID: 33741258
[TBL] [Abstract][Full Text] [Related]
11. GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study.
Verri D; Pasciuto T; Epstein E; Fruscio R; Mascilini F; Moro F; Scambia G; Valentin L; Testa AC
Int J Gynecol Cancer; 2019 Sep; 29(7):1216-1220. PubMed ID: 31248946
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.
Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS
Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672
[TBL] [Abstract][Full Text] [Related]
13. Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease.
Braga A; Elias KM; Horowitz NS; Berkowitz RS
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():81-96. PubMed ID: 33622563
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4).
Jin T; Zhou Z; Lin M; Yuan S; Xue Y; Yin T; Xu R; Chen B; Zhang J; Sun J; Li X; Hu Y; Chen L; Wang H
Am J Cancer Res; 2024; 14(3):1353-1362. PubMed ID: 38590416
[TBL] [Abstract][Full Text] [Related]
15. [The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients].
Lin JJ; Jiang F; Xiang Y; Wan XR; Feng FZ; Ren T; Yang JJ; Zhao J
Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1139-1145. PubMed ID: 36319461
[No Abstract] [Full Text] [Related]
16. Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017.
Zhu CC; Liu HY; Wei Y; Shen Z; Qian LL; Song WG; Wang J; Wu DB; Zhang XF; Zhou Y
Taiwan J Obstet Gynecol; 2019 May; 58(3):332-337. PubMed ID: 31122520
[TBL] [Abstract][Full Text] [Related]
17. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate.
Gilani MM; Fariba B; Behtash N; Ghaemmaghami F; Moosavi AS; Rezayof E
J Cancer Res Ther; 2013; 9(1):38-43. PubMed ID: 23575072
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization.
Bolze P; Schoenen S; Margaillan M; Braga A; Sauthier P; Elias K; Seckl M; Winter M; Coulter J; Lok C; Joneborg U; Undurraga Malinverno M; Hajri T; Massardier J; You B; Golfier F; Goffin F
Eur J Surg Oncol; 2024 Mar; 50(3):108012. PubMed ID: 38350264
[TBL] [Abstract][Full Text] [Related]
19. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom.
Taylor F; Short D; Winter MC; Tidy J; Savage PM; Sarwar N; Hancock BW; Seckl MJ; Coleman RE
Gynecol Oncol; 2015 Feb; 136(2):258-63. PubMed ID: 25542400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]